Table 3 from Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer: AMBER Part 2B

<p>ORR, DCR, and BOR in patients treated with cobolimab 100, 300, or 900 mg plus dostarlimab.</p>

Saved in:
Bibliografiske detaljer
Hovedforfatter: Diwakar Davar (15023480) (author)
Andre forfattere: Zeynep Eroglu (19276519) (author), Mohammed Milhem (16527976) (author), Carlos Becerra (22053822) (author), Martin Gutierrez (15360052) (author), Antoni Ribas (14837278) (author), Brian Di Pace (22053016) (author), Tianli Wang (22053019) (author), Hailei Zhang (20634191) (author), Srimoyee Ghosh (22053025) (author), Niranjan Yanamandra (22053022) (author), Theo Borgovan (22053031) (author), Shyam Srivats (22053825) (author), Angela Waszak (22053034) (author), Arindam Dhar (15016280) (author), Patricia LoRusso (15134565) (author)
Udgivet: 2025
Fag:
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!